Litcius/Paper detail

WCN25-888 DESIGN OF THE ZEUS TRIAL: INTERLEUKIN 6 INHIBITION WITH ZILTIVEKIMAB FOR CARDIOVASCULAR PROTECTION IN CHRONIC KIDNEY DISEASE

Vlado Perkovic, Katherine R. Tuttle, Naveed Sattar, A. Michael Lincoff, Ann Marie Návar, Nikolaus Marx, Anders Hvelplund, Florian M.M. Baeres, Mads D.M. Engelmann, G. Kees Hovingh, Paul M. Ridker

2025Kidney International Reports11 citationsDOIOpen Access PDF

Topics & Concepts

MedicineZEUS (particle detector)Kidney diseaseDiseaseKidneyInternal medicineIntensive care medicinePharmacologyOpticsPhysicsDeep inelastic scatteringScatteringInelastic scatteringNuclear Receptors and Signaling
WCN25-888 DESIGN OF THE ZEUS TRIAL: INTERLEUKIN 6 INHIBITION WITH ZILTIVEKIMAB FOR CARDIOVASCULAR PROTECTION IN CHRONIC KIDNEY DISEASE | Litcius